HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mary L S Queiroz Selected Research

(1,2- di(cyclopentadienyl)- 1,2- di(4- N,N- dimethylaminophenyl)ethanediyl)titanium dichloride

3/2006Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mary L S Queiroz Research Topics

Disease

5Ascites
05/2008 - 03/2002
3Neoplasms (Cancer)
01/2010 - 01/2004
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2014 - 11/2012
2Rheumatoid Arthritis
04/2014 - 11/2012
2Autoimmune Diseases (Autoimmune Disease)
04/2014 - 11/2012
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
04/2014
1Systemic Scleroderma (Systemic Sclerosis)
04/2014
1Rupture
02/2009
1Lead Poisoning (Poisoning, Lead)
09/2008
1Infections
08/2002

Drug/Important Bio-Agent (IBA)

2Silicon Dioxide (Silica)FDA LinkGeneric
04/2014 - 11/2012
2Interleukin-2 (IL2)IBA
01/2010 - 08/2002
2titanoceneIBA
03/2006 - 10/2004
1Interleukin-6 (Interleukin 6)IBA
01/2010
1Interleukin-10 (Interleukin 10)IBA
01/2010
1Cathepsin BIBA
02/2009
1Acridine OrangeIBA
02/2009
1PorphyrinsIBA
09/2008
1beta-lapachoneIBA
05/2008
1LigandsIBA
03/2006
1(1,2- di(cyclopentadienyl)- 1,2- di(4- N,N- dimethylaminophenyl)ethanediyl)titanium dichlorideIBA
03/2006
1TitaniumIBA
03/2006
1royal jellyIBA
04/2005
1Interferon-gamma (Interferon, gamma)IBA
10/2004
1InterleukinsIBA
10/2004
1Interleukin-4 (Interleukin 4)IBA
10/2004
1Concanavalin AIBA
10/2004
1CytokinesIBA
10/2004
1Conditioned Culture MediaIBA
01/2004
1titanocene dichlorideIBA
03/2002
1metalloceneIBA
03/2002

Therapy/Procedure

1Therapeutics
09/2008